Abu Dhabi – Mubasher: Mubadala Investment Company has led a $132 million Series D equity financing for US-based medical technology company Outset Medical.
A group of companies have also participated in the transaction, including Baxter Ventures, Fidelity Management and Research Company, and Partner Fund Management, according to Market Watch.
“Our investment in Outset Medical represents an exciting opportunity for Mubadala, as it is aligned with our goal of improving people’s lives while meeting a major global market need,” commented senior vice president of Pharma & Medtech at Mubadala Camilla Macapili Languille.
Outset Medical is planning to utilise the secured amount to boost its expansion and production capabilities.
“Tablo offers patients and healthcare providers a new option for more flexible and convenient dialysis treatment, improving the dialysis experience while at the same time reducing overall dialysis spend,” Outset Medical’s CEO Leslie Trigg.